Literature DB >> 1903921

Distinct structural specificities for functional coupling of the epidermal growth factor receptor to calcium-signalling versus phospholipase A2 responses.

N Hack1, B L Margolis, A Ullrich, J Schlessinger, K L Skorecki.   

Abstract

Activation of phospholipase C (PLC), leading to a rise in cytosolic Ca2+, and of phospholipase A2 (PLA2) leading to a release of arachidonic acid, are among the early transmembrane signalling events that have been demonstrated in response to occupancy of the epidermal growth factor (EGF) receptor. The tyrosine kinase activity of the receptor has been shown to be necessary for both of these responses. This requirement for the tyrosine kinase activity could conceivably implicate a role for receptor autophosphorylation in the activation of PLA2. We now demonstrate that coupling of the EGF receptor to PLA2 was not impaired in a deletion mutant (CD126) devoid of the 126 amino acids from the C-terminus which include four major autophosphorylation sites. Functional coupling of the EGF receptor to PLA2 was demonstrated using three different experimental designs: (1) release of [14C]arachidonic acid from prelabelled intact cells. (2) release of [3H]arachidonic acid from prelabelled cells permeabilized with glass beads, and (3) direct measurement of PLA2 enzymic activity in cell-free extracts using an 'in vitro' assay employing exogenous phospholipid substrate. Functional coupling of the EGF receptor to PLA2 occurred despite the absence of a demonstrable Ca(2+)-signalling response and the detection of diminished but persistent PLC-gamma phosphorylation on tyrosine residues in the CD126 deletion mutants. These results point to a clear distinction in the biochemical mechanism and role for receptor autophosphorylation in functional coupling of the EGF receptor to PLA2 activation versus Ca2+ signalling.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903921      PMCID: PMC1150090          DOI: 10.1042/bj2750563

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Vasopressin induces V1 receptors to activate phosphatidylinositol- and phosphatidylcholine-specific phospholipase C and stimulates the release of arachidonic acid by at least two pathways in the smooth muscle cell line, A-10.

Authors:  L R Grillone; M A Clark; R W Godfrey; F Stassen; S T Crooke
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

2.  A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis.

Authors:  A M Honegger; D Szapary; A Schmidt; R Lyall; E Van Obberghen; T J Dull; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

3.  Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells.

Authors:  A Fabiato; F Fabiato
Journal:  J Physiol (Paris)       Date:  1979

4.  Tyrosine phosphorylation of phospholipase C-II in vitro by the epidermal growth factor receptor.

Authors:  S Nishibe; M I Wahl; S G Rhee; G Carpenter
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

5.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

6.  EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.

Authors:  B Margolis; S G Rhee; S Felder; M Mervic; R Lyall; A Levitzki; A Ullrich; A Zilberstein; J Schlessinger
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

7.  A role for G-proteins in the epidermal growth factor stimulation of phospholipase A2 in rat kidney mesangial cells.

Authors:  N Hack; P Clayman; K Skorecki
Journal:  Biosci Rep       Date:  1990-08       Impact factor: 3.840

8.  Epidermal growth factor stimulates phospholipase A2 in vasopressin-treated rat glomerular mesangial cells.

Authors:  B L Margolis; B J Holub; D A Troyer; K L Skorecki
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

9.  Epidermal growth factor is synergistic with phorbol esters and vasopressin in stimulating arachidonate release and prostaglandin production in renal glomerular mesangial cells.

Authors:  B L Margolis; J V Bonventre; S G Kremer; J E Kudlow; K L Skorecki
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

10.  Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites.

Authors:  A Honegger; T J Dull; F Bellot; E Van Obberghen; D Szapary; A Schmidt; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  9 in total

1.  Investigation into the involvement of phospholipases A(2) and MAP kinases in modulation of AA release and cell growth in A549 cells.

Authors:  Q G Choudhury; D T McKay; R J Flower; J D Croxtall
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 2.  Transmembrane signaling in kidney health and disease.

Authors:  N Hack; A Schultz; P Clayman; H Goldberg; K L Skorecki
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

3.  Arachidonic acid mobilization is suppressed during mitosis: role of cytosolic phospholipase A2 activation.

Authors:  R D Berlin; S F Preston
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

4.  Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate.

Authors:  U Zor; E Ferber; P Gergely; K Szücs; V Dombrádi; R Goldman
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

5.  Carboxy-terminal truncations of epidermal growth factor (EGF) receptor affect diverse EGF-induced cellular responses.

Authors:  W Li; N Hack; B Margolis; A Ullrich; K Skorecki; J Schlessinger
Journal:  Cell Regul       Date:  1991-08

6.  Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration.

Authors:  C G Schalkwijk; M A van der Heijden; G Bunt; R Maas; L G Tertoolen; P M van Bergen en Henegouwen; A J Verkleij; H van den Bosch; J Boonstra
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

7.  Interleukin 1 alpha causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells.

Authors:  J Gronich; M Konieczkowski; M H Gelb; R A Nemenoff; J R Sedor
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  Characterization and identification of an epidermal-growth-factor-activated phospholipase A2.

Authors:  M Spaargaren; S Wissink; L H Defize; S W de Laat; J Boonstra
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

9.  Epidermal growth factor and phorbol myristate acetate increase expression of the mRNA for cytosolic phospholipase A2 in glomerular mesangial cells.

Authors:  A P Maxwell; H J Goldberg; A H Tay; Z G Li; G S Arbus; K L Skorecki
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.